Influenza and pneumonia vaccination rates in patients hospitalized with acute respiratory failure

References

• Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003;362:1733–45. doi:10.1016/S0140-6736(03)14776-9.
   PubMed Web of Science ®Google Scholar
• Hak E, Nordin J, Wei F, Mullooly J, Poblete S, Strikas R. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 2002;35:370–77. doi:10.1086/341403.
   PubMed Web of Science ®Google Scholar
• Mangtani P, Cumberland P, Hodgson CR, Roberts JA, Cutts FT, Hall AJ. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis. 2004;190:1–10. doi:10.1086/423326.
   PubMed Web of Science ®Google Scholar
• Blank PR, Szucs TD. Increasing influenza vaccination coverage in recommended population groups in Europe. Expert Rev Vaccines. 2009;8:425–33. doi:10.1586/erv.09.7.
   PubMed Web of Science ®Google Scholar
• National Foundation for Infectious Disease. 10 reasons to be vaccinated. [Accessed 17. Apr.12]. http://www.adultvaccination.org/10-reasons-to-be-vaccinated?css=print.
   Google Scholar
• World Health Assembly. Prevention and control of influenza pandemics and annual epidemics; 2003 Fifty-sixth World Health Assembly: Resolution WHA56.19. [Accessed 17. Apr.12]. http://www.evm-vaccines.org/pdfc/wha resolution ipd.pdf.
   Google Scholar
• Council recommendation of 2009 on seasonal influenzal vaccination. Official Journal of the European Union. L 348/71. 29.Dec.2009. [Accessed 17. Apr.12]. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:348:0071: 0072:EN:pdf.
   Google Scholar
• World Health Organization. Vaccine use. 2012; [Accessed 17. Apr.12]. http://www.who.int/influenza vaccines/use/en/
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Influenza and pneumococcal vaccination levels among persons aged > or =65 years – United States, 1999. MMWR Morb Mortal Wkly Rep. 2001;50:532–37.
   PubMedGoogle Scholar
• Oncel S, Turhan O, Huseyin PH, Yalcin AN. Status of influenza vaccination in patients presenting to two neighborhood primary health care clinics in Antalya. Infez Med. 2008;16:74–79.
   PubMedGoogle Scholar
• Satman I, Akalin S, Cakir B, Altinel S, diaVAX Study Group. The effect of physicians‘ awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological Study “diaV X”. Hum Vaccin Immunother. 2013;9:2618–26. 10.4161/hv.25826
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices—United States, 2018–19 influenza season. Recommendations and Reports. 2018 August 24;67(3):1–20. doi:10.15585/mmwr.rr6703a1.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61(40):816–19.
   PubMedGoogle Scholar
• Şenol E, Azap A, Erbay A, Alp-Çavuş S, Karakuş R, Acar A. Pneumococcal vaccine as one of the immunization coverage targets for adulthood vaccines: A consensus report of the Study Group for Adult Immunization of the Turkish Society of Clinical Microbiology and Infectious Diseases. Klimik Derg. 2018;31(1):2–18. Turkish. doi:10.5152/kd.2018.2.
   Web of Science ®Google Scholar
• Healthy people 2020. immunization and infectious diseases, objectives;.2010 Office of Disease Prevention and Health Promotion. USDHHS. [cited 2011 May 25]. Available from: http://healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=23.
   Google Scholar
• Petigara T, Zhang D. pneumococcal vaccine coverage in adults aged 19–64 years, newly diagnosed with chronic conditions in the US. Am J Preven Med. 2018;54:630–36. doi:10.1016/j.amepre.2018.01.033.
   PubMed Web of Science ®Google Scholar
• Arabyat RM, Raisch DW, Bakhireva L. Influenza vaccination for patients with chronic obstructive pulmonary disease: implications for pharmacists. Res Social Adm Pharm. 2018;14:162–69. doi:10.1016/j.sapharm.2017.02.010.
   PubMed Web of Science ®Google Scholar
• Özsu S, Uçar E, Arslan Y, Maden E, Bilgiç H. The frequency of influenza and pneumococcal vaccination in COPD. Solunum Dergisi. 2011;13:21–25. doi:10.5505/solunum.2011.88155.
   Google Scholar
• Cimen P, Unlu M, Kirakli C, Katgi N, Ucsular FD, Ayranci A, Guclu SZ. Should patients with copd be vaccinated? Respir Care. 2015;60:239–43. doi:10.4187/respcare.03350.
   PubMed Web of Science ®Google Scholar
• Aka Aktürk Ü, Görek Dilektaşlı A, Şengül A, Musaffa Salepçi B, Oktay N, Düger M, Arık Taşyıkan H, Durmuş Koçak N. Influenza and pneumonia vaccination rates and factors affecting vaccination among patients with chronic obstructive pulmonary disease. Balkan Med J. 2017;34:206–11. doi:10.4274/balkanmedj.2016.1028.
   PubMed Web of Science ®Google Scholar
• Chiatti C, Barbadoro P, Marigliano A, Ricciardi A, Di Stanislao F, Prospero E. Determinants of influenza vaccination among the adult and older Italian population with chronic obstructive pulmonary disease: a secondary analysis of the multipurpose ISTAT survey on health and health care use. Hum Vaccin. 2011;7:1021–25. doi:10.4161/hv.7.10.16849.
   PubMed Web of Science ®Google Scholar
• Arinez-Fernandez MC, Carrasco-Garrido P, Garcia-Carballo M, Hernandez-Barrera V, de Miguel AG, Jimenez-Garcia R. Determinants of pneumococcal vaccination among patients with chronic obstructive pulmonary disease in Spain. Hum Vaccin. 2006;2:99–104.
   PubMed Web of Science ®Google Scholar
• Montserrat-Capdevila J, Godoy P, Marsal JR, Cruz I, Solanes M. Effectiveness of influenza vaccination in preventing hospital admission due to exacerbations of chronic obstructive pulmonary disease. Enferm Infec Microbiol Clin. 2014;32:70–75. doi:10.1016/j.eimc.2013.02.009.
   PubMed Web of Science ®Google Scholar
• Damiani G, Federico B, Visca M, Agostini F, Ricciardi W. The impact of socioeconomic level on influenza vaccination among Italian adults and elderly: a cross-sectional study. Prev Med. 2007;45:373–79. doi:10.1016/j.ypmed.2007.07.007.
   PubMed Web of Science ®Google Scholar
• Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine. 2009;7:4018–24. doi:10.1016/j.vaccine.2009.04.029.
   Google Scholar
• Ford ES, Mannino DM, Williams SG. Asthma and influenza vaccination: findings from the 1999–2001 National Health Interview Surveys. Chest. 2003;124:783–89.
   PubMed Web of Science ®Google Scholar
• Lu PJ, Singleton JA, Rangel MC, Wortley PM, Bridges CB. Influenza vaccination trends among adults 65 years or older in the United States, 1989–2002. Arch Intern Med. 2005;165:1849–56. doi:10.1001/archinte.165.16.1849.
   PubMedGoogle Scholar
• Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, de Andrés AL, de Miguel Diez J, de Miguel A. Coverage and predictors of adherence to influenza vaccination among Spanish children and adults with asthma. Infection. 2010;38:52–57. doi:10.1007/s15010-009-9069-4.
   PubMed Web of Science ®Google Scholar
• Schiffner-Rohe J, Witt A, Hemmerling J, von Eiff C, Leverkus FW. Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk—a systematic review and meta-analysis. PLoS One. 2016;11:e0146338. doi:10.1371/journal.pone.0146338.
   PubMed Web of Science ®Google Scholar
• Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. The Cochrane Collaboration, editorCochrane Database Syst. Rev. Chichester (UK): John Wiley & Sons, Ltd; 2008. cited 2017 Oct 5. Available from10.1002/14651858.CD000422.pub2
   Google Scholar
• National Center for Health Statistics. Health, United States, 2015: with special feature on racial and ethnic health disparities. Hyattsville (MD): US Government Printing Office; 2016.
   Google Scholar
• Simonsen L, Taylor RJ, Schuck-Paim C, Lustig R, Haber M, Klugman K. Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis. Lancet Respir Med. 2014;2:387–94. doi:10.1016/S2213-2600(14)70032-3.
   PubMed Web of Science ®Google Scholar
• Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis. 2006;42:1093–101. doi:10.1086/501354.
   PubMed Web of Science ®Google Scholar
• Nordin J, Mullooly J, Poblete S, Strikas R, Petrucci R, Wei F, Rush B, Safirstein B, Wheeler D, Nichol KL. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184:665–70.
   PubMed Web of Science ®Google Scholar
• Nichol KL, D’Heilly SJ, Greenberg ME, Ehlinger E. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50–64 years. Clin Infect Dis. 2009;48:292–98. doi:10.1086/595842.
   PubMed Web of Science ®Google Scholar
• Christenson B, Lundbergh P, Hedlund J, Örtqvist Å. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet. 2001;357:1008–11. doi:10.1016/S0140-6736(00)04237-9.
   PubMed Web of Science ®Google Scholar
• Cetinoglu ED, Uzaslan E, Sayıner A, Cilli A, Kılınc O, Coskun AS, Hazar A, Kokturk N, Filiz A, Polatli M, the TURCAP Study Group 2017. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation. Hum Vaccin Immunother. 2017;13:2072–77. 10.1080/21645515.2017.1339851.
   PubMed Web of Science ®Google Scholar
• Ciblak MA, Platformu G. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013;31:518–23. doi:10.1016/j.vaccine.2012.11.022.
   PubMed Web of Science ®Google Scholar
• Çiftci F, Şen E, Demir N, Çiftci O, Erol S, Kayacan O. Beliefs, attitudes, and activities of healthcare personnel about influenza and pneumococcal vaccines. Hum Vaccin Immunother. 2018;14(1):111–17. doi:10.1080/21645515.2018.1486156.
   PubMed Web of Science ®Google Scholar
• Katsurada N, Suzuki M, Aoshima M, Yaegashi M, Ishifuji T, Asoh N, Hamashige N, Abe M, Ariyoshi K, Konosuke Morimoto and on behalf of the Adult Pneumonia Study Group-Japan. The impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study. BMC Infec Dis. 2017;17:755. doi:10.1186/s12879-017-2858-y.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2017; GOLD Updated. http://www.goldcopd.org
   Google Scholar
• Grassino A. (ATS co-chair),  Moxham J (ERS co-chair) and subcommıttee of the assembly on respıratory structure and functıon.American Thoracic Society/European Respiratory Society Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166:518–624. doi:10.1164/rccm.166.4.518.
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, et al.; Infectious Diseases Society of America, American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(2):27.
   Google Scholar